First-in-class anti-PVR mAb NTX1088 restores DNAM1 expression and enhances antitumor immunity

A. Atieh; A. Obiedat; A. Vitenshtein; G. Cinamon; K. Paz; T. Roviš; P. Kucan; L. Hirsl; O. Mandelboim; S. Jonjic; T. Pini

doi:10.1016/s0959-8049(22)00987-x

First-in-class anti-PVR mAb NTX1088 restores DNAM1 expression and enhances antitumor immunity

A. Atieh
, A. Obiedat
, A. Vitenshtein
, G. Cinamon
, K. Paz
, T. Roviš
, P. Kucan
, L. Hirsl
, O. Mandelboim
, S. Jonjic
, T. Pini

Department of Immunology and Cancer Research

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Original language	English
Pages (from-to)	S69-S70
Journal	European Journal of Cancer
Volume	174
DOIs	https://doi.org/10.1016/s0959-8049(22)00987-x
State	Published - Oct 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/s0959-8049(22)00987-x

Cite this

@article{c578b4e45d824700a14f08af7b9a1aed,

title = "First-in-class anti-PVR mAb NTX1088 restores DNAM1 expression and enhances antitumor immunity",

author = "A. Atieh and A. Obiedat and A. Vitenshtein and G. Cinamon and K. Paz and T. Rovi{\v s} and P. Kucan and L. Hirsl and O. Mandelboim and S. Jonjic and T. Pini",

year = "2022",

month = oct,

doi = "10.1016/s0959-8049(22)00987-x",

language = "אנגלית",

volume = "174",

pages = "S69--S70",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Ltd.",

}

TY - JOUR

T1 - First-in-class anti-PVR mAb NTX1088 restores DNAM1 expression and enhances antitumor immunity

AU - Atieh, A.

AU - Obiedat, A.

AU - Vitenshtein, A.

AU - Cinamon, G.

AU - Paz, K.

AU - Roviš, T.

AU - Kucan, P.

AU - Hirsl, L.

AU - Mandelboim, O.

AU - Jonjic, S.

AU - Pini, T.

PY - 2022/10

Y1 - 2022/10

UR - https://www.scopus.com/pages/publications/85143780687

U2 - 10.1016/s0959-8049(22)00987-x

DO - 10.1016/s0959-8049(22)00987-x

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

AN - SCOPUS:85143780687

SN - 0959-8049

VL - 174

SP - S69-S70

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -

First-in-class anti-PVR mAb NTX1088 restores DNAM1 expression and enhances antitumor immunity

UN SDGs

Access to Document

Other files and links

Cite this